Literature DB >> 7969066

Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.

F Ushikubi1, K Nakamura, S Narumiya.   

Abstract

The partially purified thromboxane (TX) A2 receptor was reconstituted with two species of purified heterotrimeric G proteins, Gq and Gi2, in phospholipid vesicles. The receptors reconstituted with Gq and Gi2 showed a single class of [3H]S-145 binding with Kd values of 9.6 +/- 0.7 and 12.1 +/- 1.0 nM, respectively; binding was displaced by GR32191, 9,11-epithio-11, 12-methano-thromboxane A2 (STA2), and U46619, with almost identical Ki values for each compound in the two types of reconstituted vesicles. When the receptor and Gq were reconstituted, the agonist STA2 stimulated guanosine-5'-O-(3-[35S]thio)triphosphate binding. This stimulation was half-maximal at 80 nM and reached a plateau at 1 microM STA2 stimulated the initial rate by 20-30-fold, compared with the basal rate. The stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding to Gi2 by the agonist-liganded receptor was seen in the presence of GDP. Under these conditions, 10 microM STA2 stimulated the initial rate by 1.5-2-fold, compared with the basal rate. This effect was half-maximal at 150 nM and reached a plateau at 1 microM. The agonist-liganded receptor also stimulated the GTPase activities of the reconstituted G proteins. The steady state rates of STA2-stimulated [32P]Pi release from [gamma-32P]GTP were 2.21/min.receptor and 0.87/min.receptor in the Gq- and Gi2-reconsituted vesicles, respectively, and the Kcat values of Gq and Gi2 in the presence of STA2 were 0.87 +/- 0.21 min-1 and 2.41 +/- 0.12 min-1, respectively. These results clearly show that the TXA2 receptor functionally couples to both Gq and Gi2. Consistent with this finding, STA2, by acting on the TXA2 receptor in intact platelets, inhibited prostaglandin I2-induced cAMP elevation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969066

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Specificity of G alpha q and G alpha 11 gene expression in platelets and erythrocytes. Expressions of cellular differentiation and species differences.

Authors:  G J Johnson; L A Leis; P C Dunlop
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

Review 2.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

3.  Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.

Authors:  S Ohkubo; N Nakahata; Y Ohizumi
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  RGS/Gi2alpha interactions modulate platelet accumulation and thrombus formation at sites of vascular injury.

Authors:  Rachel S Signarvic; Aleksandra Cierniewska; Timothy J Stalker; Karen P Fong; Manash S Chatterjee; Paul R Hess; Peisong Ma; Scott L Diamond; Richard R Neubig; Lawrence F Brass
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

5.  Characterization of G alpha 13-dependent plasma membrane recruitment of p115RhoGEF.

Authors:  Raja Bhattacharyya; Philip B Wedegaertner
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

6.  Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation.

Authors:  T Hirata; F Ushikubi; A Kakizuka; M Okuma; S Narumiya
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

7.  Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.

Authors:  B Klages; U Brandt; M I Simon; G Schultz; S Offermanns
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

8.  A critical role for the transient receptor potential channel type 6 in human platelet activation.

Authors:  Hari Priya Vemana; Zubair A Karim; Christine Conlon; Fadi T Khasawneh
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.